DGAP-News: Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference
Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference
DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference 23.11.2021 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference NEW YORK, November 23, 2021 - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced that Daniel Vitt, Ph.D., Chief Executive Officer and President, will participate in a fireside chat at the Piper Sandler & Co. 33rd Annual Virtual Healthcare Conference, taking place November 29-December 2, 2021. The pre-recorded presentation is available for registered attendees via the Piper Sandler conference site from Monday, November 22 to Thursday, December 2 and on the "Events and Presentations" section of Immunic's website at: https://ir.imux.com/events-and-presentations. An archived replay will be available on the company's website for a period of 90 days after the conference. About Immunic, Inc. Cautionary Statement Regarding Forward-Looking Statements Contact Information US IR Contact US Media Contact
23.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
1251141 23.11.2021